Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

IJMS, Free Full-Text

Cancers, Free Full-Text

Cancers, Free Full-Text

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer - ScienceDirect

Long Non-Coding RNAs in Triple-Negative Breast Cancer

Novel Therapies for Metastatic Triple-Negative Breast Cancer

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Molecular targets and therapeutic strategies for triple-negative breast cancer

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Impact of TP53 mutations in Triple Negative Breast Cancer